Review



rabbit anti lis1  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology rabbit anti lis1
    Rabbit Anti Lis1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 80 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti lis1/product/Santa Cruz Biotechnology
    Average 93 stars, based on 80 article reviews
    rabbit anti lis1 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Proteintech lis1
    Lis1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lis1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    lis1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech anti lis1 antibody
    Anti Lis1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti lis1 antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti lis1 antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti lis1
    Anti Lis1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti lis1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti lis1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology rabbit anti lis1
    Rabbit Anti Lis1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti lis1/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    rabbit anti lis1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    GenScript corporation human lis1 δ298-308
    a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by <t>LIS1.</t> The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.
    Human Lis1 δ298 308, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lis1 δ298-308/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    human lis1 δ298-308 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Addgene inc human lis1
    a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by <t>LIS1.</t> The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.
    Human Lis1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lis1/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    human lis1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    OriGene human pafah1b1 lis1 shrna
    (A) Quantification of IST amplitude in bRG cells following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in cortical organoids (N=3 organoid batches, 329 bRG cells, weeks 9-12). (B) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or <t>LIS1</t> shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (C) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-20). (D) Live imaging of in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs. (E) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs (N=3 experiments, 520 bRG cells). (F) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or KASH constructs, in the presence of DMSO or blebbistatin (10 μ M) (N=3 experiments, 1198 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001, ns: non-significant by two-tailed unpaired t-tests.
    Human Pafah1b1 Lis1 Shrna, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pafah1b1 lis1 shrna/product/OriGene
    Average 94 stars, based on 1 article reviews
    human pafah1b1 lis1 shrna - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher lis1 protein
    (A) Quantification of IST amplitude in bRG cells following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in cortical organoids (N=3 organoid batches, 329 bRG cells, weeks 9-12). (B) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or <t>LIS1</t> shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (C) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-20). (D) Live imaging of in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs. (E) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs (N=3 experiments, 520 bRG cells). (F) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or KASH constructs, in the presence of DMSO or blebbistatin (10 μ M) (N=3 experiments, 1198 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001, ns: non-significant by two-tailed unpaired t-tests.
    Lis1 Protein, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lis1 protein/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    lis1 protein - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by LIS1. The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by LIS1. The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques: Activation Assay, Binding Assay, Cryo-EM Sample Prep, Sample Prep

    a Heterogeneous processing of Open species class with the linker in the bent conformation. The “Partial Open Bent/LIS1” class is the same one shown in . This class was unbinned and refined to obtain a map for cryoDRGN training. Particles were downsampled and subjected to a round of low-resolution cryoDRGN training. From the training, we pulled the best and most unique clusters from the training and returned the individual subclass particles into cryoSPARC. Each subclass is defined by their linker conformation and the presence or absence of LIS1. These subclasses were further refined to their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps. b .Heterogeneous processing of the Open species class with the linker in the straight conformation. The “Open Straight/LIS1” class is the same one shown in . This class was unbinned and refined to get a refined map for RELION 3D classification without alignment. The best subclasses were taken back into cryoSPARC to further refine their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a Heterogeneous processing of Open species class with the linker in the bent conformation. The “Partial Open Bent/LIS1” class is the same one shown in . This class was unbinned and refined to obtain a map for cryoDRGN training. Particles were downsampled and subjected to a round of low-resolution cryoDRGN training. From the training, we pulled the best and most unique clusters from the training and returned the individual subclass particles into cryoSPARC. Each subclass is defined by their linker conformation and the presence or absence of LIS1. These subclasses were further refined to their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps. b .Heterogeneous processing of the Open species class with the linker in the straight conformation. The “Open Straight/LIS1” class is the same one shown in . This class was unbinned and refined to get a refined map for RELION 3D classification without alignment. The best subclasses were taken back into cryoSPARC to further refine their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques:

    a-c . Cryo-EM maps and models of the motor and tail domains of the Pre-Chi dynein-LIS1 complex are shown in three orientations: ( a ) LIS1-free face, ( b ) LIS1-bound face, and ( c ) a “top view” where the Pre-Chi motors are shown enlarged and from the perspective of the tail. LIS1 is highlighted in the LIS1-bound ( b ) and top ( c ) views. d . Local resolution map of Pre-Chi. e and f . Nucleotide states of AAA1-AAA4 in Motor 2 (Heavy Chain 2, HC-2) (e) and Motor 1 (Heavy Chain 1, HC-1) (f).

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a-c . Cryo-EM maps and models of the motor and tail domains of the Pre-Chi dynein-LIS1 complex are shown in three orientations: ( a ) LIS1-free face, ( b ) LIS1-bound face, and ( c ) a “top view” where the Pre-Chi motors are shown enlarged and from the perspective of the tail. LIS1 is highlighted in the LIS1-bound ( b ) and top ( c ) views. d . Local resolution map of Pre-Chi. e and f . Nucleotide states of AAA1-AAA4 in Motor 2 (Heavy Chain 2, HC-2) (e) and Motor 1 (Heavy Chain 1, HC-1) (f).

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques: Cryo-EM Sample Prep

    The table summarizes the conformations and nucleotide states of the Phi (yellow background) and Open (blue background) motor domains presented in this work. “LIS1” indicates how many LIS1 β-propellers are bound to the dynein motor. “Linker” refers to the overall conformation (bent, intermediate, straight) of that domain. “Stalk” refers to the register between the two helices in the coiled-coil . The nucleotide states of AAA1-AAA4 are based on our interpretation of the densities in our maps.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: The table summarizes the conformations and nucleotide states of the Phi (yellow background) and Open (blue background) motor domains presented in this work. “LIS1” indicates how many LIS1 β-propellers are bound to the dynein motor. “Linker” refers to the overall conformation (bent, intermediate, straight) of that domain. “Stalk” refers to the register between the two helices in the coiled-coil . The nucleotide states of AAA1-AAA4 are based on our interpretation of the densities in our maps.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques:

    a . Superposition of Pre-Chi (rainbow) and Phi (grey) models. HC-1 was used as the reference to align the models. Although the Pre-Chi model is shown from the LIS1-bound face, LIS1 was omitted for clarity. b . Map of interatomic vectors connecting equivalent α carbons in Phi and Pre-Chi. The length of each vector is proportional to the distance between the atoms in Phi and Pre-Chi. c . The four main interfaces between the motors in Phi are highlighted in the context of the boxed model in panel ( a ): Linker:Linker, Linker:AAA4, AAA5:AAA5, and Stalk:Stalk. d-g . Close-ups of the three interfaces highlighted in ( c ) that are disrupted by the formation of Pre-Chi: Linker:Linker ( d ), AAA5:AAA5 ( e ), and Linker:AAA4 ( f-g ). The top panel corresponds to the Phi model and the bottom panel corresponds to the Pre-Chi model. Key residues, motor chains, LIS1 ring, and the domain(s) of the motor being displayed are highlighted on each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated. There was no significant change in the Stalk:Stalk interface. There are differences in the Linker:AAA4 interface between the LIS1-bound face ( f ), and the LIS1-free face ( g ).

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Superposition of Pre-Chi (rainbow) and Phi (grey) models. HC-1 was used as the reference to align the models. Although the Pre-Chi model is shown from the LIS1-bound face, LIS1 was omitted for clarity. b . Map of interatomic vectors connecting equivalent α carbons in Phi and Pre-Chi. The length of each vector is proportional to the distance between the atoms in Phi and Pre-Chi. c . The four main interfaces between the motors in Phi are highlighted in the context of the boxed model in panel ( a ): Linker:Linker, Linker:AAA4, AAA5:AAA5, and Stalk:Stalk. d-g . Close-ups of the three interfaces highlighted in ( c ) that are disrupted by the formation of Pre-Chi: Linker:Linker ( d ), AAA5:AAA5 ( e ), and Linker:AAA4 ( f-g ). The top panel corresponds to the Phi model and the bottom panel corresponds to the Pre-Chi model. Key residues, motor chains, LIS1 ring, and the domain(s) of the motor being displayed are highlighted on each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated. There was no significant change in the Stalk:Stalk interface. There are differences in the Linker:AAA4 interface between the LIS1-bound face ( f ), and the LIS1-free face ( g ).

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques: Plasmid Preparation

    a .cryoDRGN UMAP representation. This analysis focuses on the Pre-Chi k means clusters 2-5 (highlighted by the box) from . b-e . Volumes from clusters 2-5 shown in two views: front view of the LIS1-bound face (top row) and side view (bottom row). The IC-LC Tower (labeled) is used as a reference to determine which side of Phi LIS1 is bound to.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a .cryoDRGN UMAP representation. This analysis focuses on the Pre-Chi k means clusters 2-5 (highlighted by the box) from . b-e . Volumes from clusters 2-5 shown in two views: front view of the LIS1-bound face (top row) and side view (bottom row). The IC-LC Tower (labeled) is used as a reference to determine which side of Phi LIS1 is bound to.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques: Labeling

    a . Superposition between Chi and Pre-Chi. The model of human Chi from our previous work (dark gray) and human Pre-Chi motor (rainbow) were superimposed and aligned using HC-1. b . Interatomic vectors connecting equivalent alpha carbons in Pre-Chi and Chi for the superposition shown in a. c . Pre-Chi model viewed from the LIS1-bound face with interfaces present in both Chi and Pre-Chi (#1-2 in black circles) and Pre-Chi-specific interfaces (#3-4 in red circles) highlighted. d . Close ups of the interfaces high-lighted in (c). Residues involved in the interfaces and the names of the domains interacting with LIS1 ring are highlighted in each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Superposition between Chi and Pre-Chi. The model of human Chi from our previous work (dark gray) and human Pre-Chi motor (rainbow) were superimposed and aligned using HC-1. b . Interatomic vectors connecting equivalent alpha carbons in Pre-Chi and Chi for the superposition shown in a. c . Pre-Chi model viewed from the LIS1-bound face with interfaces present in both Chi and Pre-Chi (#1-2 in black circles) and Pre-Chi-specific interfaces (#3-4 in red circles) highlighted. d . Close ups of the interfaces high-lighted in (c). Residues involved in the interfaces and the names of the domains interacting with LIS1 ring are highlighted in each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques:

    a . Representative kymographs from single-molecule motility assays with purified TMR–dynein–dynactin–BICD2 in the absence (white circle) or presence (black circle) of human LIS1 wild type or LIS1 Δ298-308 . Scale bars, 10 μm ( x ) and 100 s ( y ). b . Single-molecule velocity (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circles) or presence (black circles) of human LIS1 or LIS1 Δ298-308 . Superplots show all individual data points for each of the four technical replicates. n values for each replicate are: no LIS1, n = 70, 70, 50, 91; LIS1, n = 90, 85, 58, 117; LIS1 Δ298-308 , n = 116, 125, 89, 124. Larger shapes denote the mean of each of the four technical replicates. No LIS1 and LIS1 ** P = 0.0018, No LIS1 and LIS1 Δ298-306 ns P = 0.9955, LIS1 and LIS1 Δ298-308 ** P = 0.0012. Statistics were generated on the means of the four replicates using a One-Way ANOVA with Tukey’s multiple comparison test. c . Superplots show processive events /μm of microtubule length (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circle) or presence (black circle) of unlabeled wild type human LIS1 or LIS1 Δ298-308 . Data points are represented as triangles, circles, squares, and diamonds corresponding to single measurements within each technical replicate (no LIS1, n = 14, 12, 11, 8; LIS1, n = 12, 7, 7, 7; LIS1 Δ298-306 , n = 11, 5, 8, 9). No LIS1 and LIS1 * P = 0.012. Statistical analysis was done using a One-Way ANOVA with Tukey’s multiple comparison test. d . Role of LIS1 in the activation of dynein. This schematic is an updated version of the pathway introduced in that incorporates the Pre-Chi intermediate identified in this study.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Representative kymographs from single-molecule motility assays with purified TMR–dynein–dynactin–BICD2 in the absence (white circle) or presence (black circle) of human LIS1 wild type or LIS1 Δ298-308 . Scale bars, 10 μm ( x ) and 100 s ( y ). b . Single-molecule velocity (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circles) or presence (black circles) of human LIS1 or LIS1 Δ298-308 . Superplots show all individual data points for each of the four technical replicates. n values for each replicate are: no LIS1, n = 70, 70, 50, 91; LIS1, n = 90, 85, 58, 117; LIS1 Δ298-308 , n = 116, 125, 89, 124. Larger shapes denote the mean of each of the four technical replicates. No LIS1 and LIS1 ** P = 0.0018, No LIS1 and LIS1 Δ298-306 ns P = 0.9955, LIS1 and LIS1 Δ298-308 ** P = 0.0012. Statistics were generated on the means of the four replicates using a One-Way ANOVA with Tukey’s multiple comparison test. c . Superplots show processive events /μm of microtubule length (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circle) or presence (black circle) of unlabeled wild type human LIS1 or LIS1 Δ298-308 . Data points are represented as triangles, circles, squares, and diamonds corresponding to single measurements within each technical replicate (no LIS1, n = 14, 12, 11, 8; LIS1, n = 12, 7, 7, 7; LIS1 Δ298-306 , n = 11, 5, 8, 9). No LIS1 and LIS1 * P = 0.012. Statistical analysis was done using a One-Way ANOVA with Tukey’s multiple comparison test. d . Role of LIS1 in the activation of dynein. This schematic is an updated version of the pathway introduced in that incorporates the Pre-Chi intermediate identified in this study.

    Article Snippet: Human LIS1 Δ298-308 was generated through Genescript Express Mutagenesis & Site-Directed DNA Mutagenesis service.

    Techniques: Purification, Standard Deviation, Generated, Comparison, Activation Assay

    a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by LIS1. The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Subunit and domain organization of full-length human dynein. Individual domains and accessory chains (heavy chain (HC), intermediate chain (IC), light intermediate chain (LIC), and three light chains (LC)) are color-coded, and these colors are used throughout the paper. b . Schematic representation of a hypothetical pathway for dynein activation and assembly by LIS1. The numbers identify species—Phi (1), Chi (2), assembly of transport complex (3), and an active transport complex (4)—that are discussed in the text. The asterisk in (3) indicates a LIS1-p150 dynactin interaction , which is also discussed in the text. c . Known LIS1 binding sites on dynein are shown on the Chi motor domain from panel (b). d . Schematic representation of the cryo-EM sample preparation pipeline. e . Distribution of particles corresponding to the three main species identified in the cryo-EM dataset: Phi, Pre-Chi, and Open. Representative 2D class averages are shown. In the case of Phi and Pre-Chi, representative 2D class averages of the dynein tails, which were processed separately, are shown above those for the motor domains. LIS1 is indicated whenever present in the averages. f . Further processing identified six subclasses in the Open species. The particle distribution is indicated with the corresponding cryo-EM maps next to the section in the pie chart.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques: Activation Assay, Binding Assay, Cryo-EM Sample Prep, Sample Prep

    a Heterogeneous processing of Open species class with the linker in the bent conformation. The “Partial Open Bent/LIS1” class is the same one shown in . This class was unbinned and refined to obtain a map for cryoDRGN training. Particles were downsampled and subjected to a round of low-resolution cryoDRGN training. From the training, we pulled the best and most unique clusters from the training and returned the individual subclass particles into cryoSPARC. Each subclass is defined by their linker conformation and the presence or absence of LIS1. These subclasses were further refined to their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps. b .Heterogeneous processing of the Open species class with the linker in the straight conformation. The “Open Straight/LIS1” class is the same one shown in . This class was unbinned and refined to get a refined map for RELION 3D classification without alignment. The best subclasses were taken back into cryoSPARC to further refine their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a Heterogeneous processing of Open species class with the linker in the bent conformation. The “Partial Open Bent/LIS1” class is the same one shown in . This class was unbinned and refined to obtain a map for cryoDRGN training. Particles were downsampled and subjected to a round of low-resolution cryoDRGN training. From the training, we pulled the best and most unique clusters from the training and returned the individual subclass particles into cryoSPARC. Each subclass is defined by their linker conformation and the presence or absence of LIS1. These subclasses were further refined to their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps. b .Heterogeneous processing of the Open species class with the linker in the straight conformation. The “Open Straight/LIS1” class is the same one shown in . This class was unbinned and refined to get a refined map for RELION 3D classification without alignment. The best subclasses were taken back into cryoSPARC to further refine their final map. The Fourier Shell Correlation (FSC) plots are shown next to the respective final maps.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques:

    a-c . Cryo-EM maps and models of the motor and tail domains of the Pre-Chi dynein-LIS1 complex are shown in three orientations: ( a ) LIS1-free face, ( b ) LIS1-bound face, and ( c ) a “top view” where the Pre-Chi motors are shown enlarged and from the perspective of the tail. LIS1 is highlighted in the LIS1-bound ( b ) and top ( c ) views. d . Local resolution map of Pre-Chi. e and f . Nucleotide states of AAA1-AAA4 in Motor 2 (Heavy Chain 2, HC-2) (e) and Motor 1 (Heavy Chain 1, HC-1) (f).

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a-c . Cryo-EM maps and models of the motor and tail domains of the Pre-Chi dynein-LIS1 complex are shown in three orientations: ( a ) LIS1-free face, ( b ) LIS1-bound face, and ( c ) a “top view” where the Pre-Chi motors are shown enlarged and from the perspective of the tail. LIS1 is highlighted in the LIS1-bound ( b ) and top ( c ) views. d . Local resolution map of Pre-Chi. e and f . Nucleotide states of AAA1-AAA4 in Motor 2 (Heavy Chain 2, HC-2) (e) and Motor 1 (Heavy Chain 1, HC-1) (f).

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques: Cryo-EM Sample Prep

    The table summarizes the conformations and nucleotide states of the Phi (yellow background) and Open (blue background) motor domains presented in this work. “LIS1” indicates how many LIS1 β-propellers are bound to the dynein motor. “Linker” refers to the overall conformation (bent, intermediate, straight) of that domain. “Stalk” refers to the register between the two helices in the coiled-coil . The nucleotide states of AAA1-AAA4 are based on our interpretation of the densities in our maps.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: The table summarizes the conformations and nucleotide states of the Phi (yellow background) and Open (blue background) motor domains presented in this work. “LIS1” indicates how many LIS1 β-propellers are bound to the dynein motor. “Linker” refers to the overall conformation (bent, intermediate, straight) of that domain. “Stalk” refers to the register between the two helices in the coiled-coil . The nucleotide states of AAA1-AAA4 are based on our interpretation of the densities in our maps.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques:

    a . Superposition of Pre-Chi (rainbow) and Phi (grey) models. HC-1 was used as the reference to align the models. Although the Pre-Chi model is shown from the LIS1-bound face, LIS1 was omitted for clarity. b . Map of interatomic vectors connecting equivalent α carbons in Phi and Pre-Chi. The length of each vector is proportional to the distance between the atoms in Phi and Pre-Chi. c . The four main interfaces between the motors in Phi are highlighted in the context of the boxed model in panel ( a ): Linker:Linker, Linker:AAA4, AAA5:AAA5, and Stalk:Stalk. d-g . Close-ups of the three interfaces highlighted in ( c ) that are disrupted by the formation of Pre-Chi: Linker:Linker ( d ), AAA5:AAA5 ( e ), and Linker:AAA4 ( f-g ). The top panel corresponds to the Phi model and the bottom panel corresponds to the Pre-Chi model. Key residues, motor chains, LIS1 ring, and the domain(s) of the motor being displayed are highlighted on each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated. There was no significant change in the Stalk:Stalk interface. There are differences in the Linker:AAA4 interface between the LIS1-bound face ( f ), and the LIS1-free face ( g ).

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Superposition of Pre-Chi (rainbow) and Phi (grey) models. HC-1 was used as the reference to align the models. Although the Pre-Chi model is shown from the LIS1-bound face, LIS1 was omitted for clarity. b . Map of interatomic vectors connecting equivalent α carbons in Phi and Pre-Chi. The length of each vector is proportional to the distance between the atoms in Phi and Pre-Chi. c . The four main interfaces between the motors in Phi are highlighted in the context of the boxed model in panel ( a ): Linker:Linker, Linker:AAA4, AAA5:AAA5, and Stalk:Stalk. d-g . Close-ups of the three interfaces highlighted in ( c ) that are disrupted by the formation of Pre-Chi: Linker:Linker ( d ), AAA5:AAA5 ( e ), and Linker:AAA4 ( f-g ). The top panel corresponds to the Phi model and the bottom panel corresponds to the Pre-Chi model. Key residues, motor chains, LIS1 ring, and the domain(s) of the motor being displayed are highlighted on each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated. There was no significant change in the Stalk:Stalk interface. There are differences in the Linker:AAA4 interface between the LIS1-bound face ( f ), and the LIS1-free face ( g ).

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques: Plasmid Preparation

    a .cryoDRGN UMAP representation. This analysis focuses on the Pre-Chi k means clusters 2-5 (highlighted by the box) from . b-e . Volumes from clusters 2-5 shown in two views: front view of the LIS1-bound face (top row) and side view (bottom row). The IC-LC Tower (labeled) is used as a reference to determine which side of Phi LIS1 is bound to.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a .cryoDRGN UMAP representation. This analysis focuses on the Pre-Chi k means clusters 2-5 (highlighted by the box) from . b-e . Volumes from clusters 2-5 shown in two views: front view of the LIS1-bound face (top row) and side view (bottom row). The IC-LC Tower (labeled) is used as a reference to determine which side of Phi LIS1 is bound to.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques: Labeling

    a . Superposition between Chi and Pre-Chi. The model of human Chi from our previous work (dark gray) and human Pre-Chi motor (rainbow) were superimposed and aligned using HC-1. b . Interatomic vectors connecting equivalent alpha carbons in Pre-Chi and Chi for the superposition shown in a. c . Pre-Chi model viewed from the LIS1-bound face with interfaces present in both Chi and Pre-Chi (#1-2 in black circles) and Pre-Chi-specific interfaces (#3-4 in red circles) highlighted. d . Close ups of the interfaces high-lighted in (c). Residues involved in the interfaces and the names of the domains interacting with LIS1 ring are highlighted in each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Superposition between Chi and Pre-Chi. The model of human Chi from our previous work (dark gray) and human Pre-Chi motor (rainbow) were superimposed and aligned using HC-1. b . Interatomic vectors connecting equivalent alpha carbons in Pre-Chi and Chi for the superposition shown in a. c . Pre-Chi model viewed from the LIS1-bound face with interfaces present in both Chi and Pre-Chi (#1-2 in black circles) and Pre-Chi-specific interfaces (#3-4 in red circles) highlighted. d . Close ups of the interfaces high-lighted in (c). Residues involved in the interfaces and the names of the domains interacting with LIS1 ring are highlighted in each panel. Interactions are shown with dotted lines, with their distances (in Å) indicated.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques:

    a . Representative kymographs from single-molecule motility assays with purified TMR–dynein–dynactin–BICD2 in the absence (white circle) or presence (black circle) of human LIS1 wild type or LIS1 Δ298-308 . Scale bars, 10 μm ( x ) and 100 s ( y ). b . Single-molecule velocity (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circles) or presence (black circles) of human LIS1 or LIS1 Δ298-308 . Superplots show all individual data points for each of the four technical replicates. n values for each replicate are: no LIS1, n = 70, 70, 50, 91; LIS1, n = 90, 85, 58, 117; LIS1 Δ298-308 , n = 116, 125, 89, 124. Larger shapes denote the mean of each of the four technical replicates. No LIS1 and LIS1 ** P = 0.0018, No LIS1 and LIS1 Δ298-306 ns P = 0.9955, LIS1 and LIS1 Δ298-308 ** P = 0.0012. Statistics were generated on the means of the four replicates using a One-Way ANOVA with Tukey’s multiple comparison test. c . Superplots show processive events /μm of microtubule length (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circle) or presence (black circle) of unlabeled wild type human LIS1 or LIS1 Δ298-308 . Data points are represented as triangles, circles, squares, and diamonds corresponding to single measurements within each technical replicate (no LIS1, n = 14, 12, 11, 8; LIS1, n = 12, 7, 7, 7; LIS1 Δ298-306 , n = 11, 5, 8, 9). No LIS1 and LIS1 * P = 0.012. Statistical analysis was done using a One-Way ANOVA with Tukey’s multiple comparison test. d . Role of LIS1 in the activation of dynein. This schematic is an updated version of the pathway introduced in that incorporates the Pre-Chi intermediate identified in this study.

    Journal: bioRxiv

    Article Title: Cryo-EM captures early intermediate steps in dynein activation by LIS1

    doi: 10.1101/2025.01.10.632485

    Figure Lengend Snippet: a . Representative kymographs from single-molecule motility assays with purified TMR–dynein–dynactin–BICD2 in the absence (white circle) or presence (black circle) of human LIS1 wild type or LIS1 Δ298-308 . Scale bars, 10 μm ( x ) and 100 s ( y ). b . Single-molecule velocity (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circles) or presence (black circles) of human LIS1 or LIS1 Δ298-308 . Superplots show all individual data points for each of the four technical replicates. n values for each replicate are: no LIS1, n = 70, 70, 50, 91; LIS1, n = 90, 85, 58, 117; LIS1 Δ298-308 , n = 116, 125, 89, 124. Larger shapes denote the mean of each of the four technical replicates. No LIS1 and LIS1 ** P = 0.0018, No LIS1 and LIS1 Δ298-306 ns P = 0.9955, LIS1 and LIS1 Δ298-308 ** P = 0.0012. Statistics were generated on the means of the four replicates using a One-Way ANOVA with Tukey’s multiple comparison test. c . Superplots show processive events /μm of microtubule length (mean ± standard deviation of the means of each replicate) of TMR–dynein–dynactin–BICD2 complexes in the absence (white circle) or presence (black circle) of unlabeled wild type human LIS1 or LIS1 Δ298-308 . Data points are represented as triangles, circles, squares, and diamonds corresponding to single measurements within each technical replicate (no LIS1, n = 14, 12, 11, 8; LIS1, n = 12, 7, 7, 7; LIS1 Δ298-306 , n = 11, 5, 8, 9). No LIS1 and LIS1 * P = 0.012. Statistical analysis was done using a One-Way ANOVA with Tukey’s multiple comparison test. d . Role of LIS1 in the activation of dynein. This schematic is an updated version of the pathway introduced in that incorporates the Pre-Chi intermediate identified in this study.

    Article Snippet: The plasmids for full-length human cytoplasmic-dynein 1 (Addgene plasmid # 111903) and human LIS1 (Addgene plasmid #132539) were gifts from Andrew Carter (LMB-MRC).

    Techniques: Purification, Standard Deviation, Generated, Comparison, Activation Assay

    (A) Quantification of IST amplitude in bRG cells following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in cortical organoids (N=3 organoid batches, 329 bRG cells, weeks 9-12). (B) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (C) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-20). (D) Live imaging of in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs. (E) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs (N=3 experiments, 520 bRG cells). (F) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or KASH constructs, in the presence of DMSO or blebbistatin (10 μ M) (N=3 experiments, 1198 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001, ns: non-significant by two-tailed unpaired t-tests.

    Journal: bioRxiv

    Article Title: Two independent translocation modes drive neural stem cell dissemination into the human fetal cortex

    doi: 10.1101/2025.01.08.631865

    Figure Lengend Snippet: (A) Quantification of IST amplitude in bRG cells following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in cortical organoids (N=3 organoid batches, 329 bRG cells, weeks 9-12). (B) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (C) Live imaging of mitotic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-20). (D) Live imaging of in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs. (E) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or LIS1 shRNA constructs (N=3 experiments, 520 bRG cells). (F) Quantification of IST amplitude in in vitro interphasic human bRG cells expressing control or KASH constructs, in the presence of DMSO or blebbistatin (10 μ M) (N=3 experiments, 1198 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001, ns: non-significant by two-tailed unpaired t-tests.

    Article Snippet: The following plasmids were used in this study: MSCV-IRES-GFP (Tannishtha Reya, Addgene 20672); VSVG (a gift from P. Benaroch), Human EZR shRNA (TF308420, Origene), Human STK10 shRNA (TF320540, Origene), Human SLK shRNA (TG320620, Origene), Human DYNC1H1 shRNA (TL313335, Origene), Human RDX shRNA (TL309884, Origene), Human MSN shRNA (TL311375, Origene), Human ECT2 shRNA (TL304854, Origene), Human VIM shRNA (TL308419, Origene), Human PAFAH1B1 (LIS1) shRNA (TL310628, Origene), Dominant Negative KASH.

    Techniques: Imaging, Expressing, Control, shRNA, Construct, In Vitro, Two Tailed Test

    (A) Live imaging of interphasic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (B) Live imaging of interphasic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-18). (C) Quantification of IST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (N=3 organoid batches, 899 bRG cells, week 8-11). Two independent shRNA plasmids were used for each knockdown. (D) Quantification of MST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (N=3 organoid batches, 899 bRG cells, week 8-11). (E) Quantification of IST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (N=3 fetal samples, 385 bRG cells, pcw 16-20). (F) Quantification of MST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (N=3 fetal samples, 385 bRG cells, pcw 16-20). (G) Live imaging of interphasic human bRG cells expressing GFP in control cortical organoids and two different patient-derived LIS1-mutated organoids (week 8-11). (H) Quantification of IST amplitude in control cortical organoids and two different patient-derived LIS1-mutated organoids (N=3 organoid batches, 397 bRG cells, week 8-11). (I) Quantification of MST amplitude in control cortical organoids and two different patient-derived LIS1-mutated organoids (N=3 organoid batches, 397 bRG cells, week 8-11). (J) Immunostaining for SOX2 and Nesprin-2 in cortical organoids expressing GFP or the KASH dominant negative together with GFP (week 9). Red arrows indicate nuclear envelope of construct-expressing cells. (K) Live imaging of interphasic human bRG cells expressing control or KASH constructs in human cortical organoids (week 8). KASH plasmid co-expresses GFP. (L) Live imaging of interphasic human bRG cells expressing control or KASH constructs in human fetal tissue (pcw 16). KASH plasmid co-expresses GFP. (M) Quantification of IST amplitude in human bRG cells expressing control or KASH constructs in human cortical organoids (N=3 organoid batches, weeks 8-11, 201 bRG cells). (N) Quantification of MST amplitude in human bRG cells expressing control or KASH constructs in human cortical organoids (N=3 organoid batches, weeks 8-11, 201 bRG cells). (O) Quantification of IST amplitude in human bRG cells expressing control or KASH constructs in human fetal tissue (N=2 fetal samples, pcw 16-18, 40 bRG cells). (P) Quantification of MST amplitude in human bRG cells expressing control or KASH constructs in human fetal tissue (N=2 fetal samples, pcw 16-18, 40 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ****p<0,0001, ns: non-significant by two-tailed unpaired t-tests.

    Journal: bioRxiv

    Article Title: Two independent translocation modes drive neural stem cell dissemination into the human fetal cortex

    doi: 10.1101/2025.01.08.631865

    Figure Lengend Snippet: (A) Live imaging of interphasic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (week 8-11). shRNA plasmids co-express GFP. (B) Live imaging of interphasic human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (pcw 16-18). (C) Quantification of IST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (N=3 organoid batches, 899 bRG cells, week 8-11). Two independent shRNA plasmids were used for each knockdown. (D) Quantification of MST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human cortical organoids (N=3 organoid batches, 899 bRG cells, week 8-11). (E) Quantification of IST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (N=3 fetal samples, 385 bRG cells, pcw 16-20). (F) Quantification of MST amplitude in human bRG cells expressing control, DYNC1H1 or LIS1 shRNA constructs in human fetal tissue (N=3 fetal samples, 385 bRG cells, pcw 16-20). (G) Live imaging of interphasic human bRG cells expressing GFP in control cortical organoids and two different patient-derived LIS1-mutated organoids (week 8-11). (H) Quantification of IST amplitude in control cortical organoids and two different patient-derived LIS1-mutated organoids (N=3 organoid batches, 397 bRG cells, week 8-11). (I) Quantification of MST amplitude in control cortical organoids and two different patient-derived LIS1-mutated organoids (N=3 organoid batches, 397 bRG cells, week 8-11). (J) Immunostaining for SOX2 and Nesprin-2 in cortical organoids expressing GFP or the KASH dominant negative together with GFP (week 9). Red arrows indicate nuclear envelope of construct-expressing cells. (K) Live imaging of interphasic human bRG cells expressing control or KASH constructs in human cortical organoids (week 8). KASH plasmid co-expresses GFP. (L) Live imaging of interphasic human bRG cells expressing control or KASH constructs in human fetal tissue (pcw 16). KASH plasmid co-expresses GFP. (M) Quantification of IST amplitude in human bRG cells expressing control or KASH constructs in human cortical organoids (N=3 organoid batches, weeks 8-11, 201 bRG cells). (N) Quantification of MST amplitude in human bRG cells expressing control or KASH constructs in human cortical organoids (N=3 organoid batches, weeks 8-11, 201 bRG cells). (O) Quantification of IST amplitude in human bRG cells expressing control or KASH constructs in human fetal tissue (N=2 fetal samples, pcw 16-18, 40 bRG cells). (P) Quantification of MST amplitude in human bRG cells expressing control or KASH constructs in human fetal tissue (N=2 fetal samples, pcw 16-18, 40 bRG cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ****p<0,0001, ns: non-significant by two-tailed unpaired t-tests.

    Article Snippet: The following plasmids were used in this study: MSCV-IRES-GFP (Tannishtha Reya, Addgene 20672); VSVG (a gift from P. Benaroch), Human EZR shRNA (TF308420, Origene), Human STK10 shRNA (TF320540, Origene), Human SLK shRNA (TG320620, Origene), Human DYNC1H1 shRNA (TL313335, Origene), Human RDX shRNA (TL309884, Origene), Human MSN shRNA (TL311375, Origene), Human ECT2 shRNA (TL304854, Origene), Human VIM shRNA (TL308419, Origene), Human PAFAH1B1 (LIS1) shRNA (TL310628, Origene), Dominant Negative KASH.

    Techniques: Imaging, Expressing, Control, shRNA, Construct, Knockdown, Derivative Assay, Immunostaining, Dominant Negative Mutation, Plasmid Preparation, Two Tailed Test

    (A) Live imaging of an in vitro GBM cell (line U3123) performing IST. (B) Live imaging of an in vitro GBM cell (line U3123) performing MST. (C) Quantification of the fraction of cells performing IST, in 9 GBM lines and compared to in vitro bRG cells (N=3 replicates per line, 1130 cells). (D) Quantification of the fraction of cells performing MST, in 9 GBM lines and compared to in vitro bRG cells (N=3 replicates per line, 1130 cells). (E) Immunostaining for bRG markers SOX2 and HOPX in U3123 GBM line. (F) Live imaging of U3123 GBM line during interphase, treated with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M). (G) Quantification of IST amplitude following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in U3123 GBM line (N=3 experiments, 274 GBM cells). (H) Live imaging of U3123 GBM line during mitosis, treated with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M). (I) Quantification of MST amplitude following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in U3123 GBM line (N=3 experiments, 274 GBM cells). (J) Live imaging of interphasic U3123 GBM cells expressing control, LIS1 shRNA or KASH dominant negative constructs. (K) Quantification of IST amplitude in U3123 GBM cells expressing control or LIS1 shRNA constructs. (N=3 experiments, 359 GBM cells). (L) Quantification of IST amplitude in U3123 GBM cells expressing control or KASH dominant negative constructs (N=3 experiments, 300 GBM cells). (M) Live imaging of mitotic U3123 GBM cells expressing control, Moesin or Vimentin shRNA constructs. (N) Quantification of MST amplitude U3123 GBM cells expressing control, Moesin or Vimentin shRNA (N=3 experiments, 149 GBM cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001; ****p<0,0001, ns: non-significant by two-tailed unpaired t-tests.

    Journal: bioRxiv

    Article Title: Two independent translocation modes drive neural stem cell dissemination into the human fetal cortex

    doi: 10.1101/2025.01.08.631865

    Figure Lengend Snippet: (A) Live imaging of an in vitro GBM cell (line U3123) performing IST. (B) Live imaging of an in vitro GBM cell (line U3123) performing MST. (C) Quantification of the fraction of cells performing IST, in 9 GBM lines and compared to in vitro bRG cells (N=3 replicates per line, 1130 cells). (D) Quantification of the fraction of cells performing MST, in 9 GBM lines and compared to in vitro bRG cells (N=3 replicates per line, 1130 cells). (E) Immunostaining for bRG markers SOX2 and HOPX in U3123 GBM line. (F) Live imaging of U3123 GBM line during interphase, treated with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M). (G) Quantification of IST amplitude following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in U3123 GBM line (N=3 experiments, 274 GBM cells). (H) Live imaging of U3123 GBM line during mitosis, treated with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M). (I) Quantification of MST amplitude following treatment with DMSO, nocodazole (1 μ M) or blebbistatin (10 μ M) in U3123 GBM line (N=3 experiments, 274 GBM cells). (J) Live imaging of interphasic U3123 GBM cells expressing control, LIS1 shRNA or KASH dominant negative constructs. (K) Quantification of IST amplitude in U3123 GBM cells expressing control or LIS1 shRNA constructs. (N=3 experiments, 359 GBM cells). (L) Quantification of IST amplitude in U3123 GBM cells expressing control or KASH dominant negative constructs (N=3 experiments, 300 GBM cells). (M) Live imaging of mitotic U3123 GBM cells expressing control, Moesin or Vimentin shRNA constructs. (N) Quantification of MST amplitude U3123 GBM cells expressing control, Moesin or Vimentin shRNA (N=3 experiments, 149 GBM cells). Yellow arrowheads indicate bRG cell soma, and green and red arrowheads indicate daughter cells. Data are presented as mean values +/− SD. Scale bar = 20 µm. All live imaging montages are in hours:minutes. **p<0,01; ***p<0,001; ****p<0,0001, ns: non-significant by two-tailed unpaired t-tests.

    Article Snippet: The following plasmids were used in this study: MSCV-IRES-GFP (Tannishtha Reya, Addgene 20672); VSVG (a gift from P. Benaroch), Human EZR shRNA (TF308420, Origene), Human STK10 shRNA (TF320540, Origene), Human SLK shRNA (TG320620, Origene), Human DYNC1H1 shRNA (TL313335, Origene), Human RDX shRNA (TL309884, Origene), Human MSN shRNA (TL311375, Origene), Human ECT2 shRNA (TL304854, Origene), Human VIM shRNA (TL308419, Origene), Human PAFAH1B1 (LIS1) shRNA (TL310628, Origene), Dominant Negative KASH.

    Techniques: Imaging, In Vitro, Immunostaining, Expressing, Control, shRNA, Dominant Negative Mutation, Construct, Two Tailed Test